Cullinan Therapeutics
CGEM
#5717
Rank
$0.89 B
Marketcap
$15.30
Share price
-3.10%
Change (1 day)
61.22%
Change (1 year)

Cullinan Therapeutics (CGEM) - Cash on Hand

Cash on Hand as of June 2024 : $0.66 Billion USD

According to Cullinan Therapeutics's latest financial reports the company has $0.66 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cullinan Therapeutics - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$0.46 B-0.05%
2022-12-31$0.46 B60.88%
2021-12-31$0.29 B38.18%
2020-12-31$0.21 B113.13%
2019-12-31$98.63 M191.53%
2018-12-31$33.83 M